Method of treating functional bowel disorders
2 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a method of treating functional bowel disorders in a subject in need of treatment. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity. The invention further relates to a method of treating a functional bowel disorder in a subject in need thereof, comprising coadministering to said subject a first amount of a 5-HT3 antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount. In addition, the method of the invention comprises administering a NARI alone. The functional bowel disorders which can be treated according to the method of the invention include IBS, functional abdominal bloating, functional constipation and functional diarrhea.
-
Citations
130 Claims
-
1-62. -62. (canceled)
- 63. (new) A method for treating a functional bowel disorder comprising administering from about 0.05 mg to about 500 mg per day of a compound of formula I:
- 77. (new) A method for treating a functional bowel disorder comprising administering from about 0.03 mg to about 300 mg per day of a compound of formula I:
- 91. (new) A method for treating a functional bowel disorder comprising administering from about 0.02 mg to about 200 mg per day of a compound of formula I:
- 105. (new) A method for treating a functional bowel disorder comprising administering from about 0.1 mg to about 50 mg per day of a compound of formula I:
- 118. (new) A method for treating a functional bowel disorder comprising administering from about 0.5 mg to about 10 mg per day of a compound of formula I:
Specification